Stay updated with breaking news from Capital Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AbilityPharma closes €7 million round to fully fund its international Phase 2b clinical trial with the antitumor drug ABTL0812 in pancreatic cancer patients.
Meyer Burger Technology AG / Key word: Capital Increase/Strategic Company Decision Meyer Burger calls EGM to approve CHF 200 to 250 million rights issue to finance the completion of its...
Investments - SeedBlink, the investment & equity management platform dedicated to European tech startups, announces a strategic partnership with Capital Cell,
This collaboration marks a significant step in bridging the gap between innovative technology ventures and investors across Europe. ...
SeedBlink, the investment & equity management platform dedicated to European tech startups, has announced a strategic partnership with Capital Cell, Spain’s leading investment platform specializing in Biotech and Healthtech.